Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Synaptic microRNAs Coordinately Regulate Synaptic mRNAs: Perturbation by Chronic Alcohol Consumption.

Most D, Leiter C, Blednov YA, Harris RA, Mayfield RD.

Neuropsychopharmacology. 2016 Jan;41(2):538-48. doi: 10.1038/npp.2015.179. Epub 2015 Jun 24.

2.

Glycine receptors containing α2 or α3 subunits regulate specific ethanol-mediated behaviors.

Blednov YA, Benavidez JM, Black M, Leiter CR, Osterndorff-Kahanek E, Harris RA.

J Pharmacol Exp Ther. 2015 Apr;353(1):181-91. doi: 10.1124/jpet.114.221895. Epub 2015 Feb 12.

3.

GABAA receptors containing ρ1 subunits contribute to in vivo effects of ethanol in mice.

Blednov YA, Benavidez JM, Black M, Leiter CR, Osterndorff-Kahanek E, Johnson D, Borghese CM, Hanrahan JR, Johnston GA, Chebib M, Harris RA.

PLoS One. 2014 Jan 16;9(1):e85525. doi: 10.1371/journal.pone.0085525. eCollection 2014.

4.

Regulation of SIK1 abundance and stability is critical for myogenesis.

Stewart R, Akhmedov D, Robb C, Leiter C, Berdeaux R.

Proc Natl Acad Sci U S A. 2013 Jan 2;110(1):117-22. doi: 10.1073/pnas.1212676110. Epub 2012 Dec 19.

5.

Systematic identification of functional residues in mammalian histone H2AX.

Chen WT, Alpert A, Leiter C, Gong F, Jackson SP, Miller KM.

Mol Cell Biol. 2013 Jan;33(1):111-26. doi: 10.1128/MCB.01024-12. Epub 2012 Oct 29.

6.

Acanthamoeba keratitis: the persistence of cases following a multistate outbreak.

Yoder JS, Verani J, Heidman N, Hoppe-Bauer J, Alfonso EC, Miller D, Jones DB, Bruckner D, Langston R, Jeng BH, Joslin CE, Tu E, Colby K, Vetter E, Ritterband D, Mathers W, Kowalski RP, Acharya NR, Limaye AP, Leiter C, Roy S, Lorick S, Roberts J, Beach MJ.

Ophthalmic Epidemiol. 2012 Aug;19(4):221-5. doi: 10.3109/09286586.2012.681336.

PMID:
22775278
7.

Stinging nettle cream for osteoarthritis.

Rayburn K, Fleischbein E, Song J, Allen B, Kundert M, Leiter C, Bush T.

Altern Ther Health Med. 2009 Jul-Aug;15(4):60-1. No abstract available.

PMID:
19623834
8.

Reversibility of androgen deprivation therapy in patients with prostate cancer.

Fridmans A, Chertin B, Koulikov D, Lindenberg T, Gelber H, Leiter C, Farkas A, Spitz IM.

J Urol. 2005 Mar;173(3):784-9.

PMID:
15711270
9.
10.

Combination of ABO blood group incompatibility and glucose-6-phosphate dehydrogenase deficiency: effect on hemolysis and neonatal hyperbilirubinemia.

Kaplan M, Vreman HJ, Hammerman C, Leiter C, Rudensky B, MacDonald MG, Stevenson DK.

Acta Paediatr. 1998 Apr;87(4):455-7.

PMID:
9628306
11.

Ophthalmic compounding: techniques for achieving sterility.

Leiter CW.

Int J Pharm Compd. 1998 May-Jun;2(3):189. No abstract available.

PMID:
23989539
12.

Comparison of commercial screening tests for glucose-6-phosphate dehydrogenase deficiency in the neonatal period.

Kaplan M, Leiter C, Hammerman C, Rudensky B.

Clin Chem. 1997 Jul;43(7):1236-7. No abstract available.

13.

Contribution of haemolysis to jaundice in Sephardic Jewish glucose-6-phosphate dehydrogenase deficient neonates.

Kaplan M, Vreman HJ, Hammerman C, Leiter C, Abramov A, Stevenson DK.

Br J Haematol. 1996 Jun;93(4):822-7.

PMID:
8703811
14.

Conjugated bilirubin in neonates with glucose-6-phosphate dehydrogenase deficiency.

Kaplan M, Rubaltelli FF, Hammerman C, Vilei MT, Leiter C, Abramov A, Muraca M.

J Pediatr. 1996 May;128(5 Pt 1):695-7.

PMID:
8627445
15.

Enzymatic activity in glucose-6-phosphate dehydrogenase-normal and -deficient neonates measured with a commercial kit.

Kaplan M, Leiter C, Hammerman C, Rudensky B.

Clin Chem. 1995 Nov;41(11):1665-7. No abstract available.

Supplemental Content

Loading ...
Support Center